Journal of Neuroimmune Pharmacology

, Volume 7, Issue 4, pp 904–913 | Cite as

Wnt Signaling in the Pathogenesis of Multiple Sclerosis-Associated Chronic Pain

ORIGINAL ARTICLE

Abstract

Many multiple sclerosis (MS) patients develop chronic pain, but the underlying pathological mechanism is unknown. Mice with experimental autoimmune encephalomyelitis (EAE) have been widely used to model MS-related neurological complications, including CNS demyelination, neuroinflammation and motor impairments. Similar to MS patients, EAE mice also develop chronic pain. We are interested in elucidating the potential involvement of Wnt signaling in the pathogenesis of chronic pain in EAE mice. In this study, we characterized the expression of Wnt signaling proteins in the spinal cord dorsal horn (SCDH) of EAE mice, by immunoblotting and immunostaining. The EAE model was created by immunization of adult mice (C57BL/6, 10 weeks) with myelin oligodendrocyte glycoprotein (MOG) 35–55. Robust mechanical hyperalgesia and allodynia were developed in both fore- and hindpaws of the EAE mice. Wnt3a, a prototypical Wnt ligand for the canonical pathway, was significantly increased in the SCDH of the EAE mice. Another key protein in the canonical pathway, ß-catenin, was also significantly up-regulated. In addition, Wnt5a, a prototypic Wnt ligand for the non-canonical pathway, and its receptor (co-receptor) Ror2 were also up-regulated in the SCDH of the EAE mice. We further found that Wnt5a antagonist Box5 and β-catenin inhibitor indomethacin attenuated mechanical allodynia in the EAE mice. Our data collectively suggest that Wnt signaling pathways are up-regulated in the SCDH of the EAE mice and that aberrant activation of Wnt signaling contributes to the development of EAE-related chronic pain.

Keywords

Pain Multiple sclerosis Experimental autoimmune encephalomyelitis Spinal cord dorsal horn Wnt β-catenin 

References

  1. Aicher SA, Silverman MB, Winkler CW, Bebo BF Jr (2004) Hyperalgesia in an animal model of multiple sclerosis. Pain 110:560–570PubMedCrossRefGoogle Scholar
  2. Callahan BL, Gil AS, Levesque A, Mogil JS (2008) Modulation of mechanical and thermal nociceptive sensitivity in the laboratory mouse by behavioral state. J Pain: Official J Am Pain Soc 9:174–184CrossRefGoogle Scholar
  3. Cerpa W, Gambrill A, Inestrosa NC, Barria A (2011) Regulation of NMDA-receptor synaptic transmission by Wnt signaling. The J Neurosci: the Official J Soc Neurosci 31:9466–9471CrossRefGoogle Scholar
  4. Chalk JB, McCombe PA, Smith R, Pender MP (1994) Clinical and histological findings in proteolipid protein-induced experimental autoimmune encephalomyelitis (EAE) in the Lewis rat. Distribution of demyelination differs from that in EAE induced by other antigens. J Neurol Sci 123:154–161PubMedCrossRefGoogle Scholar
  5. Chen J, Park CS, Tang SJ (2006) Activity-dependent synaptic Wnt release regulates hippocampal long term potentiation. J Biol Chem 281:11910–11916PubMedCrossRefGoogle Scholar
  6. Chew LJ, Shen W, Ming X, Senatorov VV Jr, Chen HL, Cheng Y, Hong E, Knoblach S, Gallo V (2011) SRY-box containing gene 17 regulates the Wnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells. The J Neurosci: the official J Soc Neurosci 31:13921–13935CrossRefGoogle Scholar
  7. Cuitino L, Godoy JA, Farias GG, Couve A, Bonansco C, Fuenzalida M, Inestrosa NC (2010) Wnt-5a modulates recycling of functional GABAA receptors on hippocampal neurons. The J Neurosci: the official J Soc Neurosci 30:8411–8420CrossRefGoogle Scholar
  8. Dal Canto MC, Melvold RW, Kim BS, Miller SD (1995) Two models of multiple sclerosis: experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus (TMEV) infection. A pathological and immunological comparison. Microsc Res Tech 32:215–229PubMedCrossRefGoogle Scholar
  9. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S, Sanai N, Franklin RJ, Rowitch DH (2009) Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Gene Dev 23:1571–1585PubMedCrossRefGoogle Scholar
  10. Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, Franklin RJ, Rowitch DH (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009–1016PubMedCrossRefGoogle Scholar
  11. Farias GG, Alfaro IE, Cerpa W, Grabowski CP, Godoy JA, Bonansco C, Inestrosa NC (2009) Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons. J Biol Chem 284:15857–15866PubMedCrossRefGoogle Scholar
  12. Feigenson K, Reid M, See J, Crenshaw EB 3rd, Grinspan JB (2009) Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42:255–265PubMedCrossRefGoogle Scholar
  13. Feigenson K, Reid M, See J, Crenshaw IE, Grinspan JB (2011) Canonical Wnt signalling requires the BMP pathway to inhibit oligodendrocyte maturation. ASN neuro 3:e00061PubMedCrossRefGoogle Scholar
  14. Fradkin LG, Garriga G, Salinas PC, Thomas JB, Yu X, Zou Y (2005) Wnt signaling in neural circuit development. The Journal of neuroscience: the official journal of the Society for Neuroscience 25:10376–10378CrossRefGoogle Scholar
  15. Galceran J, Miyashita-Lin EM, Devaney E, Rubenstein JL, Grosschedl R (2000) Hippocampus development and generation of dentate gyrus granule cells is regulated by LEF1. Development 127:469–482PubMedGoogle Scholar
  16. Goessling W, North TE, Loewer S, Lord AM, Lee S, Stoick-Cooper CL, Weidinger G, Puder M, Daley GQ, Moon RT, Zon LI (2009) Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration. Cell 136:1136–1147PubMedCrossRefGoogle Scholar
  17. Gogolla N, Galimberti I, Deguchi Y, Caroni P (2009) Wnt signaling mediates experience-related regulation of synapse numbers and mossy fiber connectivities in the adult hippocampus. Neuron 62:510–525PubMedCrossRefGoogle Scholar
  18. Jenei V, Sherwood V, Howlin J, Linnskog R, Safholm A, Axelsson L, Andersson T (2009) A t-butyloxycarbonyl-modified Wnt5a-derived hexapeptide functions as a potent antagonist of Wnt5a-dependent melanoma cell invasion. Proc Natl Acad Sci USA 106:19473–19478PubMedCrossRefGoogle Scholar
  19. Kiguchi N, Kobayashi Y, Kishioka S (2011) Chemokines and cytokines in neuroinflammation leading to neuropathic pain. Curr Opin Pharmacol.Google Scholar
  20. Lee HK, Jeong S (2006) β-Catenin stabilizes cyclooxygenase-2 mRNA by interacting with AU-rich elements of 3′-UTR. Nucleic Acids Res 34:5705–5714PubMedCrossRefGoogle Scholar
  21. Li B, Zhong L, Yang X, Andersson T, Huang M, Tang SJ (2011) WNT5A Signaling contributes to abeta-induced neuroinflammation and neurotoxicity. PloS one 6:e22920PubMedCrossRefGoogle Scholar
  22. Maguschak KA, Ressler KJ (2012) The dynamic role of beta-catenin in synaptic plasticity. Neuropharmacology 62:78–88PubMedCrossRefGoogle Scholar
  23. Michalski D, Liebig S, Thomae E, Hinz A, Bergh FT (2011) Pain in patients with multiple sclerosis: a complex assessment including quantitative and qualitative measurements provides for a disease-related biopsychosocial pain model. J Pain Res 4:219–225PubMedCrossRefGoogle Scholar
  24. Mikels AJ, Nusse R (2006) Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context. PLoS Biol 4:e115PubMedCrossRefGoogle Scholar
  25. Mikels A, Minami Y, Nusse R (2009) Ror2 receptor requires tyrosine kinase activity to mediate Wnt5A signaling. J Biol Chem 284:30167–30176PubMedCrossRefGoogle Scholar
  26. Moore CS, Hebb AL, Blanchard MM, Crocker CE, Liston P, Korneluk RG, Robertson GS (2008) Increased X-linked inhibitor of apoptosis protein (XIAP) expression exacerbates experimental autoimmune encephalomyelitis (EAE). J Neuroimmunol 203:79–93PubMedCrossRefGoogle Scholar
  27. Murase S, Mosser E, Schuman EM (2002) Depolarization drives beta-Catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 35:91–105PubMedCrossRefGoogle Scholar
  28. Nuñez F, Bravo S, Cruzat F, Montecino M, De Ferrari GV (2011) Wnt/β-Catenin signaling enhances cyclooxygenase-2 (COX2) transcriptional activity in gastric cancer cells. PLoS ONE 6:e18562PubMedCrossRefGoogle Scholar
  29. Oishi I, Suzuki H, Onishi N, Takada R, Kani S, Ohkawara B, Koshida I, Suzuki K, Yamada G, Schwabe GC, Mundlos S, Shibuya H, Takada S, Minami Y (2003) The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8:645–654PubMedCrossRefGoogle Scholar
  30. Okuda T, Yu LM, Cingolani LA, Kemler R, Goda Y (2007) beta-Catenin regulates excitatory postsynaptic strength at hippocampal synapses. Proc Natl Acad Sci USA 104:13479–13484PubMedCrossRefGoogle Scholar
  31. Olechowski CJ, Truong JJ, Kerr BJ (2009) Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE). Pain 141:156–164PubMedCrossRefGoogle Scholar
  32. Olechowski CJ, Parmar A, Miller B, Stephan J, Tenorio G, Tran K, Leighton J, Kerr BJ (2010) A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE). Pain 149:565–572PubMedCrossRefGoogle Scholar
  33. Reynolds R, Dawson M, Papadopoulos D, Polito A, Di Bello IC, Pham-Dinh D, Levine J (2002) The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS. J Neurocytol 31:523–536PubMedCrossRefGoogle Scholar
  34. Rodrigues DH, Sachs D, Teixeira AL (2009) Mechanical hypernociception in experimental autoimmune encephalomyelitis. Arquivos de neuro-psiquiatria 67:78–81Google Scholar
  35. Rosso SB, Sussman D, Wynshaw-Boris A, Salinas PC (2005) Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat Neurosci 8:34–42PubMedCrossRefGoogle Scholar
  36. Sahores M, Salinas PC (2011) Activity-mediated synapse formation a role for wnt-fz signaling. Curr Top Dev Biol 97:119–136PubMedCrossRefGoogle Scholar
  37. Salinas PC, Zou Y (2008) Wnt signaling in neural circuit assembly. Annu Rev Neurosci 31:339–358PubMedCrossRefGoogle Scholar
  38. Salthouse TN (1964) Luxol fast blue g as a Myelin Stain. Stain Tech 39:123Google Scholar
  39. Shimizu T, Kagawa T, Wada T, Muroyama Y, Takada S, Ikenaka K (2005) Wnt signaling controls the timing of oligodendrocyte development in the spinal cord. Dev Biol 282:397–410PubMedCrossRefGoogle Scholar
  40. Shubayev VI, Kato K, Myers RR (2010) Cytokines in pain. In: Kruger L, Light AR (eds) Translational pain research: from mouse to man. (Boca Raton, FLGoogle Scholar
  41. Tang SJ, Reis G, Kang H, Gingras AC, Sonenberg N, Schuman EM (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc Natl Acad Sci USA 99:467–472PubMedCrossRefGoogle Scholar
  42. Thibault K, Calvino B, Pezet S (2011) Characterisation of sensory abnormalities observed in an animal model of multiple sclerosis: a behavioural and pharmacological study. Eur J Pain 15:231 e231-216Google Scholar
  43. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD (2010) NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. The J Neurosci: the Official J Soc Neurosci 30:16383–16390CrossRefGoogle Scholar
  44. Varela-Nallar L, Alfaro IE, Serrano FG, Parodi J, Inestrosa NC (2010) Wingless-type family member 5A (Wnt-5a) stimulates synaptic differentiation and function of glutamatergic synapses. Proc Natl Acad Sci USA 107:21164–21169PubMedCrossRefGoogle Scholar
  45. Yoshikawa S, McKinnon RD, Kokel M, Thomas JB (2003) Wnt-mediated axon guidance via the Drosophila Derailed receptor. Nature 422:583–588PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Neuroscience and Cell BiologyThe University of Texas Medical BranchGalvestonUSA

Personalised recommendations